Proteins & Antibodies
Cell Line Development
Cell Banking
Tech Transfer
Process Development
GMP Manufacturing
Analytics & Bioassays
Vaccines & Viral Vectors
Vector Design
Production Systems
Process Development
GMP Manufacturing
Analytics & Bioassays
LV, AAV, MVA
Protein & Antibody
ADCC Enhancement
Transposase System
Expression Cell Lines
Vaccines & Viral Vector
MVA Vector Platform
LV Production System
Designer Cell Line
Proteins & Antibodies
- Cell Line Development
- Cell Banking (MCBs & WCBs)
- Process Development (USP/DSP)
- GMP Manufacturing
- Technology Transfer
- Analytics & Bioassays
- Biosimilars & Biobetters
Viral Vectors & Vaccines
- Producer Cell Line Development
- Process Development
- GMP Manufacturing
- Quality Analytics
- AAV Production
- Lentivirus Production
- Poxvirus Production
Proteins & Antibodies
- GlymaxX® - ADCC Enhancement/
Glycoengineering - DirectedLuck® - Transposase System
- CHO.RiGHT® - Producer Cell Line
Viral Vectors & Vaccines
- MVA-CR19 - Vector Platform
- Lenti.RiGHT® - Production System
- DirectedLuck® - Transposase System
- AGE1® - Designer Cell Line
"Thanks to ProBioGen's continuous support and regularly provided valuable information — not only on technical challenges but also urgent issues associated with the project — our teams were able to bring a product from their facility to clinic as scheduled, within several months, here in Japan."
Director, CMC Development | Chiome Bioscience Inc.
"Working with ProBioGen has been a highly rewarding experience. Their technical expertise, dedication to quality, and reliability, as well as industry-standard-exceeding results reaffirmed ProBioGen as the right partner for Marea. MAR002 holds promise as a first-in-class treatment for acromegaly, a life-shortening disease often with serious complications. We appreciate ProBioGen's support throughout the process and look forward to continuing our collaboration as we advance to the next stages."
Chief Development Operations Officer | Marea Therapeutics
German Quality
- Scientific expertise in everything we do
- Proprietary technologies for a superior outcome
- More than 70% of satisfied customers seen in repeat business
Proven Flexibility
- Our experienced CMC managers interfacing with clients on individual needs
- Customized and modular approach allows for outstanding flexibility
- Our proprietary technologies also ensure this flexibility
Fast Timelines
- One-stop-shop with integrated services and technologies
- Early risk mitigation strategies
- Parallel project starts with multiple molecules possible
